Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion

Atherosclerosis
Adele CasaschiAndre G Theriault

Abstract

The purpose of the present study was to examine the role of taxifolin, a plant flavonoid, on several aspects involving apolipoprotein B (apoB) secretion and triglyceride (TG) availability in HepG2 cells. Taxifolin was shown by ELISA to markedly reduce apoB secretion under basal and lipid-rich conditions up to 63% at 200 micromol/L. As to the mechanism underlying this effect, we examined whether taxifolin exerted its effect by limiting TG availability in the microsomal lumen essential for lipoprotein assembly. Taxifolin was shown to inhibit microsomal TG synthesis by 37% and its subsequent transfer into the lumen (-26%). The reduction in synthesis was due to a decrease in diacylglycerol acyltransferase (DGAT) activity (-35%). The effect on DGAT activity was found to be non-competitive and non-transcriptional in nature. Both DGAT-1 and DGAT-2 mRNA expression remained essentially unchanged suggesting the point of regulation may be at the post-transcriptional level. Evidence is accumulating that microsomal triglyceride transfer protein (MTP) is also involved in determining the amount of lumenal TG available for lipoprotein assembly and secretion. Taxifolin was shown to inhibit this enzyme by 41%. Whether the reduction in TG accumul...Continue Reading

References

Jul 1, 1995·Physiological Reviews·G M Reaven
Jun 1, 1995·Current Opinion in Lipidology·M R Taskinen
Jul 1, 1993·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·J Macri, K Adeli
Jun 1, 1997·Current Opinion in Lipidology·G F Lewis
Aug 15, 2000·Annual Review of Nutrition·R A ColemanD M Muoio
Mar 27, 2001·Current Opinion in Lipidology·G S Shelness, J A Sellers
Aug 2, 2001·The Journal of Biological Chemistry·S CasesR V Farese
Apr 9, 2002·Molecular and Cellular Biochemistry·Winnie L YeeAndre Theriault
Jan 9, 2003·Journal of Lipid Research·M Mahmood HussainPaul Dreizen

❮ Previous
Next ❯

Citations

Oct 30, 2008·Current Opinion in Lipidology·Mohammed Mahmood Hussain, Ahmed Bakillah
Jun 9, 2011·Molecular Cancer·Maurice Israël, Laurent Schwartz
Mar 7, 2006·Lipids in Health and Disease·Jingting JiangNing Xu
Mar 15, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Minjie LinDanyan Xu
Jun 15, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Clarissa Gerhäuser
Sep 18, 2007·Apoptosis : an International Journal on Programmed Cell Death·Jeong-Yeh YangClifton A Baile
May 26, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Xiaodan WangSu Zeng
Jul 1, 2010·BMC Complementary and Alternative Medicine·Pratibha V NerurkarVivek R Nerurkar
Jul 30, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marta González-Castejón, Arantxa Rodriguez-Casado
Apr 20, 2012·European Journal of Pharmacology·Anita Elaine Weidmann
Apr 24, 2007·Diabetes Research and Clinical Practice·Tomohiko SasaseMutsuyoshi Matsushita
Sep 22, 2007·The Journal of Nutrition·Geoffrey K MaiyohAndre G Theriault
Jul 22, 2019·Phytochemistry·Christudas Sunil, Baojun Xu
Sep 24, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xinyu JiYongyan Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.